Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

8.16
Delayed Data
As of Feb 21
 +0.20 / +2.51%
Today’s Change
7.80
Today|||52-Week Range
18.00
-17.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues2.2M22.9M130.0M83.3M
 
 
 
 
 
Depreciation And Amortization2.9M1.9M727.0K2.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses103.9M101.2M118.3M219.1M
 
 
 
 
 
Research And Development89.7M84.4M95.2M178.2M
 
 
 
 
 
Total Operating Expenses106.8M103.1M119.0M221.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-104.6M-80.2M11.0M-137.9M
 
 
 
 
 
Extraordinary Credit2.2M--0.00703.0K
 
 
 
Extraordinary Charge0.00-20.1M-9.5M--
 
 
 
Interest Expense On Debt2.0M2.3M6.7M6.6M
 
 
 
 
 
Other Expenses59.0K2.3M572.0K2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-104.1M-100.4M-4.7M-141.4M
 
 
 
 
 
Income Taxes0.00-70.0K0.000.00
 
 
Net Income-104.1M-100.3M-4.7M-141.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.3M76.3M103.6M103.9M
 
 
 
 
 
Shares To Calculate EPS Diluted73.3M76.3M103.6M103.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.40-$1.33-$0.05-$1.36
 
 
 
 
 
EPS Diluted-$1.40-$1.33-$0.05-$1.36